Saturday, April 30, 2022

Biotech company studies show complete remissions in patients with blood cancers using natural killer cells

Good news! Cancer is history (soon)! I did not have time to more thoroughly evaluate these reports, but the news sound promising.

"Nkrarta is among companies developing cell therapies for cancer based on NK [natural killer] cells, the body’s first line of defense against foreign invaders.
Nkarta said Monday that two experimental, off-the-shelf treatments, both made from engineered natural killer cells, induced complete responses in patients with advanced forms of blood cancer. The results marked the first reveal of clinical data from its research programs. ..."

Nkarta studies show complete remissions in patients with blood cancers (behind paywall)

No comments: